👏Outstanding science across the fields of #NeuroOncology: Congratulations to our #EANO2026 award winners for Best Poster Presentation: P. Watchmaker (Clinical research), A. Tron (Basic research), A. Mathioudaki (Translational research), and S. Nordentoft (Supportive care & quality of life research)!

Strong EAN presence at #EANO2026 in Rome. Congratulations to Prof. Roberta Rudà, former EAN Neuro-oncology Panel Co-Chair, on becoming EANO President. Together with colleagues across Europe, EAN continues to strengthen neurology-based neuro-oncology and support the next generation of specialists.

From ROAM/EORTC 1308 to VIGOR and new glioma research, EORTC abstracts contributed important evidence presented at #EANO2026.

🔗 Read more: https://www.eortc.org/blog/2026/09/28/eortc-presents-new-results-at-eano/

EANO #EORTCbrain

Presented at this year’s #EANO2026 Congress in Rome and simultaneously published in The Lancet.

Thank you to @thelancet.com for the excellent collaboration!

Good to see our doctoral candidate @soumi07.bsky.social presenting her work at #EANO2026! We hope the whole team from @institutducerveau.bsky.social had a great EANO meeting 🤗

📢 Just presented at #EANO2026 – and now published in Neuro-Oncology!
The study “Impact of [18F]FET-PET on MRI-Based Radiotherapy Target Volumes in Newly Diagnosed Glioblastoma: Results from the FET-PET in Glioblastoma (FIG) Study TROG 18.06”, presented by Eng-Siew Koh: doi.org/10.1093/neuo...

Radiotherapy after surgery halves risk of recurrence in a type of brain tumour that can often grow back, trial shows.

Find out more in The Lancet: spkl.io/633297TFyz #EANO2026 @eanoassociation.bsky.social

Had a great time in Rome at the #EANO2026 @eanoassociation.bsky.social !
It was a wonderful experience: top notch science presented at the meeting, seeing good old friends and making new connections, and finally seeing some beautiful parts of Rome while eating the best gelato on earth! Grazie!

Now at #EANO2026 on #radiotherapy in glioblastoma 🧠:

➡️ #FET-PET-informed target volumes were larger than MRI-only volumes
➡️ MRI-based plans showed lower coverage

📄Take-home: MRI-only planning may under-cover disease, but whether this translates into better tumour control still needs to be shown

In the #UNITED/MR-guided adaptive #Radiotherapy for high-grade glioma:

➡️ 5-mm adaptive CTV margins, with target volumes 40-71% smaller than conventional volumes
➡️ Marginal failure low (4%)
➡️ Higher lymphocyte counts at the end of RT
➡️ Treatment-induced severe lymphopenia: 6.8% vs 14.9%

#EANO2026

Interesting data from #STERIMGLI at #EANO2026 on #re-irradiation + #durvalumab for recurrent glioblastoma:

➡️ HF-SRT 24 Gy/3 fx
➡️ Primary OS endpoint not met in ITT population (16.1 vs 13.3 months)
➡️ QoL and cognition maintained
➡️ Exploratory analyses suggest a stronger OS in WHO 2021 glioblastoma

The final day of the #EANO2026 scientific programme is underway in Rome!
There is still plenty of science, clinical research and exchange ahead as we come together for another day across the #NeuroOncology community.
www.eano.eu/eano2026/pro...
#btsm #BrainTumor #EANO

Full days, lots to listen and to learn, and good company!

Padova Neuro-oncology @iov_irccs at #EANO2026 in lovely Rome

Poster session time at #EANO2026!

Don’t miss the opportunity to have engaging discussions with presenters and colleagues 🗣️
Here few posters that caught my attention 👇🏻 Go and check it out yourselves
#RadiationOncology #NeuroOncology

Another fantastic day at #EANO2026!!! Thank you Professor Platten and Professor Minniti for preparing such a robust, high quality meeting!!!

Extremely nice to see a large Polish delegation at @EANOassociation #EANO2026 - recently formed Polish Society for Neuro-Oncology is represented well at this year’s meeting! Makes me very happy 😃

Thank you for visiting our poster @MayoClinicNeuro @MayoClinic
#EANO2026

Prof. Susan Short made the Pro case for #radiotherapy + chemotherapy in every patient with grade 3 IDH-mutant #glioma.
A great debate around which treatments we can, and should, deliver to this population #EANO2026

📢 Just presented at #EANO2026 – and now published in Neuro-Oncology! The study “Plasma proteomics for prognostic stratification in newly diagnosed primary central nervous system lymphoma”, presented by first author Tamara Künzle, is now available in Neuro-Oncology.
🔗 doi.org/10.1093/neuo...

📢 Just presented at #EANO2026 – now published in Neuro-Oncology! The study “Potentially Inappropriate Care at the End of Life in Patients with Glioblastoma: A Single-Center Observational Cohort Study”, presented by first author Robin Pieterman, is now available open access.
🔗 doi.org/10.1093/neuo...